BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 26425429)

  • 21. State of the art on the initiatives and activities relevant to risk assessment and risk management of nanotechnologies in the food and agriculture sectors.
    Takeuchi MT; Kojima M; Luetzow M
    Food Res Int; 2014 Oct; 64():976-981. PubMed ID: 30011741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of a web-based nanomaterial database by big data curation and modeling friendly nanostructure annotations.
    Yan X; Sedykh A; Wang W; Yan B; Zhu H
    Nat Commun; 2020 May; 11(1):2519. PubMed ID: 32433469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Machine learning-integrated omics for the risk and safety assessment of nanomaterials.
    Ahmad F; Mahmood A; Muhmood T
    Biomater Sci; 2021 Mar; 9(5):1598-1608. PubMed ID: 33443512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoinformatics workshop report: Current resources, community needs, and the proposal of a collaborative framework for data sharing and information integration.
    Harper SL; Hutchison JE; Baker N; Ostraat M; Tinkle S; Steevens J; Hoover MD; Adamick J; Rajan K; Gaheen S; Cohen Y; Nel A; Cachau RE; Tuominen M
    Comput Sci Discov; 2013; 6(1):14008. PubMed ID: 24454543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanomaterials for environmental remediation: investigating the role of nanoinformatics in support of environmental, health, and safety oversight of nanotechnologies at the local level.
    Massawe E
    J Environ Health; 2013; 76(1):8-17. PubMed ID: 23947284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanosilver conductive ink: A case study for evaluating the potential risk of nanotechnology under hypothetical use scenarios.
    Martin DP; Melby NL; Jordan SM; Bednar AJ; Kennedy AJ; Negrete ME; Chappell MA; Poda AR
    Chemosphere; 2016 Nov; 162():222-7. PubMed ID: 27497530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review and perspective of existing research on the release of nanomaterials from solid nanocomposites.
    Froggett SJ; Clancy SF; Boverhof DR; Canady RA
    Part Fibre Toxicol; 2014 Apr; 11():17. PubMed ID: 24708765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials.
    Stone V; Johnston HJ; Balharry D; Gernand JM; Gulumian M
    Risk Anal; 2016 Aug; 36(8):1538-50. PubMed ID: 27285586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Environmental and health effects of nanomaterials in nanotextiles and façade coatings.
    Som C; Wick P; Krug H; Nowack B
    Environ Int; 2011 Aug; 37(6):1131-42. PubMed ID: 21397331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research strategies for safety evaluation of nanomaterials, part VII: evaluating consumer exposure to nanoscale materials.
    Thomas T; Thomas K; Sadrieh N; Savage N; Adair P; Bronaugh R
    Toxicol Sci; 2006 May; 91(1):14-9. PubMed ID: 16476686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contribution of research to the responsible and sustainable development of nanotechnologies].
    Iavicoli S; Boccuni F
    G Ital Med Lav Ergon; 2008; 30(3 Suppl):110-4. PubMed ID: 19288800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanotechnology and the Nanodermatology Society.
    Nasir A; Friedman A
    J Drugs Dermatol; 2010 Jul; 9(7):879-82. PubMed ID: 20677548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the occupational, consumer and environmental exposure to engineered nanomaterials used in 10 technology sectors.
    Nowack B; Brouwer C; Geertsma RE; Heugens EH; Ross BL; Toufektsian MC; Wijnhoven SW; Aitken RJ
    Nanotoxicology; 2013 Sep; 7(6):1152-6. PubMed ID: 22783888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of Research Trends and Methods in Nano Environmental, Health, and Safety Risk Analysis.
    Erbis S; Ok Z; Isaacs JA; Benneyan JC; Kamarthi S
    Risk Anal; 2016 Aug; 36(8):1644-65. PubMed ID: 26882074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensing beyond Senses: An Overview of Outstanding Strides in Architecting Nanopolymer-Enabled Sensors for Biomedical Applications.
    Malini S; Roy A; Raj K; Raju KSA; Ali IH; Mahesh B; Yadav KK; Islam S; Jeon BH; Lee SS
    Polymers (Basel); 2022 Feb; 14(3):. PubMed ID: 35160590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Considerations on the EU definition of a nanomaterial: science to support policy making.
    Bleeker EA; de Jong WH; Geertsma RE; Groenewold M; Heugens EH; Koers-Jacquemijns M; van de Meent D; Popma JR; Rietveld AG; Wijnhoven SW; Cassee FR; Oomen AG
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):119-25. PubMed ID: 23200793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linking Exposures of Particles Released From Nano-Enabled Products to Toxicology: An Integrated Methodology for Particle Sampling, Extraction, Dispersion, and Dosing.
    Pal AK; Watson CY; Pirela SV; Singh D; Chalbot MC; Kavouras I; Demokritou P
    Toxicol Sci; 2015 Aug; 146(2):321-33. PubMed ID: 25997654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomaterial health effects--Part 2: Uncertainties and recommendations for the future.
    Powell MC; Kanarek MS
    WMJ; 2006 May; 105(3):18-23. PubMed ID: 16749320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.